|
|
CSB-CL822736HU
|
Cusabio |
|
10 μg plasmid + 200μl Glycerol |
|
|
|
ELI-09804h
|
Lifescience Market |
|
96 Tests |
|
|
|
abx387258-96tests
|
Abbexa |
|
96 tests |
|
|
|
|
|
|
|
|
|
CSB-CL822736HU-10ug
|
Cusabio |
|
10ug |
|
|
|
EF009518
|
Lifescience Market |
|
96 Tests |
|
|
|
|
|
|
|
|
|
ABC-KH5095
|
AcceGen |
|
1 vial |
|
|
|
ABC-KD5095
|
AcceGen |
|
1 vial |
|
|
|
IHUFAM133APLLY20UG
|
Innovative research |
|
each |
|
|
|
OCOA20977-20UG
|
Aviva Systems Biology |
|
20ug |
|
|
|
OCOA05111-20UG
|
Aviva Systems Biology |
|
20ug |
|
|
|
GWB-9296F0
|
GenWay Biotech |
|
0.1 mg |
|
|
|
SC328401
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
SC328402
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
SC328403
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
SC309191
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RG214870
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RG229763
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RG229764
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RG229765
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
|
|
RC229763
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RC229764
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RC229765
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RC214870
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OAAB07628-400UL
|
Aviva Systems Biology |
|
400ul |
|
|
|
RC229764L4
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RC229765L4
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RC229764L3
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
RC229765L3
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
AP51531PU-N
|
Origene Technologies GmbH |
|
400 µl |
|
|
|
RC229763L3V
|
Origene Technologies GmbH |
|
200 µl |
|
|
|
RC229763L4V
|
Origene Technologies GmbH |
|
200 µl |
|
|
|
RC214870L1V
|
Origene Technologies GmbH |
|
200 µl |
|
|
|
RC214870L2V
|
Origene Technologies GmbH |
|
200 µl |
|
|
|
RC214870L3V
|
Origene Technologies GmbH |
|
200 µl |
|